Choosing between those two tyrosine kinase inhibitors may prove challenging. Two randomized trials have been conducted to facilitate treatment choices, COMPARZ, and PISCES.
Book Title: First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES.
Author:
Published on 2015 by
ISBN: /
Total Page:
Book Category:
Book is About: Carcinoma treatment
Download First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. eBook
Abstract : Purpose of review: In patients with metastatic renal cell carcinoma and favourable or intermediate risk, sunitinib, pazopanib, and bevacizumab along with interferon have been recommended with identical evidence level I, recommendation grade A. In clinical practice, most physicians and patients are likely to favour an oral treatment (i.e., sunitinib or pazopanib). Choosing between those two tyrosine kinase inhibitors may prove challenging. Two randomized trials have been conducted to facilitate treatment choices, COMPARZ, and PISCES. We discuss below the design of these trials, their results, their potential interpretation, and their clinical implications for selecting treatment. Recent findings: Both trials were reported to meet the primary endpoint (i.e., noninferiority of pazopanib versus sunitinib) and patient's preference of pazopanib over sunitinib. However, several methodological aspects have raised doubts about the reliability of these conclusions. Pitfalls include the patients selected for the final analysis, discrepancies of results between the per protocol and intention-to-treat populations, the time points at which quality of life and disease were assessed. Summary: A rigorous head-to-head comparison of pazopanib versus sunitinib is yet to be performed. Clinical considerations and physicans' experience, rather than the reported results of these trials, may continue to influence treatment choices.
Our website offers free Carcinoma treatment Ebooks to download. First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. is the one of great book to have from us, a free ebooks portal, the best free ebooks download library. You can find and download free ebooks in categories. No registration is required to download free e-books. We have huge collection of Carcinoma treatment and ebooks. Each downloadable ebook has a short review with a description. You can find over thousand of ebooks that are free to download. Get ton of books with us, the open directory for free ebooks and download links, the best place to read ebooks and search free download ebooks.Carcinoma treatment ebooks free
download First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. ebook as PDF, EPUB, MOBI, AZW and AZW3, FB2, DJVU, LIT, RFT, IBA, LRS, LRF, and LRX.
download ebooks
There are so many ebooks about First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. that are available to have. Thinking of having First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. ebook? You are in the right place. Get the ebook First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. by: .
Book Details:
- Book was ranked at 26 by Google Books for First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES.
- First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. published by since 2015 with ISBNs. The book ISBN 13 Code is and ISBN 10 Code is
- Reading Mode in Text Status is false and Reading Mode in Image Status is false
- The book has " Pages" is Printed at BOOK under Category
- Rated by Raters and have average rate at ""
- eBook written in en
- Book Preview Address: http://books.google.com/books?id=t2DbvQEACAAJ&dq=Carcinoma+treatment&hl=&cd=345&source=gbs_api
Book Preview
The Button is not working? Try The Alternative links for "First-line Treatment of Metastatic Renal Cell Carcinoma After COMPARZ and PISCES. by: ":
- Server 2: SECURE LINK